Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatic Steatosis
100%
Hepatitis C Virus
100%
Direct-acting Antivirals
100%
Cirrhosis
33%
Hepatocellular Carcinoma
33%
Hepatocytes
33%
Fibrosis
33%
Insulin Resistance
33%
Steatosis
33%
Lipid Deposition
33%
Infected Individual
16%
Lipid Metabolism
16%
Liver
16%
Genetic Factors
16%
Alcohol
16%
Polymorphism
16%
Comorbidity
16%
Antiviral Drugs
16%
Genotype
16%
Ribavirin
16%
Hepatitis C Virus Infection
16%
Metabolic Syndrome
16%
Interferon-α (IFN-α)
16%
Transmembrane
16%
Treatment Duration
16%
Treatment Regimen
16%
Treatment Experience
16%
Triglyceride Deposition
16%
Obesity Resistance
16%
Virus Response
16%
Non-cirrhotic Patients
16%
PNPLA3
16%
HIV Drugs
16%
Host Lipids
16%
Hepatitis C Virus Eradication
16%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Liver
100%
Antivirus Agent
100%
Hepatitis C Virus
100%
Antiviral Drug
50%
Liver Cell Carcinoma
33%
Fibrosis
33%
Liver Cirrhosis
33%
Steatosis
33%
Insulin Resistance
33%
HIV
16%
Hepatitis C
16%
Viral Clearance
16%
Ribavirin
16%
Metabolic Syndrome X
16%
Phospholipase
16%
Interferon
16%
Triacylglycerol
16%
Synapsin II
16%
Hepatitis B Virus
16%
Comorbidity
16%
Biochemistry, Genetics and Molecular Biology
Hepatitis C Virus
100%
Hepatocyte
28%
Insulin Resistance
28%
Lipid Storage
28%
Human Immunodeficiency Virus
14%
Genetic Determinism
14%
Viral Clearance
14%
Genotyping
14%
Triglyceride
14%
Ribavirin
14%
Lipid Metabolism
14%
Hepatitis B Virus
14%
Patatin-Like Phospholipase
14%
Comorbidity
14%
Interferon
14%